US Bionics, Inc., also known as SuitX, is a pioneering company headquartered in the United States, specialising in the development of advanced robotic exoskeletons. Founded in 2014, the company has rapidly established itself as a leader in the bionics industry, focusing on enhancing mobility and rehabilitation for individuals with physical challenges. With major operations across North America, US Bionics is renowned for its innovative products, including the Phoenix exoskeleton, which is designed to assist individuals with lower limb disabilities. This unique technology not only improves mobility but also promotes independence, setting US Bionics apart in a competitive market. The company’s commitment to research and development has led to significant advancements in wearable robotics, solidifying its position as a key player in the field.
How does US Bionics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
US Bionics, Inc.'s score of 42 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
US Bionics, Inc., headquartered in the United States, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Ottobock SE & Co. KGaA, which may influence its climate commitments and emissions reporting. As of now, US Bionics, Inc. has not established any documented reduction targets or initiatives. However, it is important to note that the company’s climate strategy may be informed by the sustainability practices and targets set by its parent organisation, Ottobock SE & Co. KGaA, which operates at a higher cascade level. Given the absence of direct emissions data and reduction commitments, US Bionics, Inc. appears to be in the early stages of developing its climate action framework. The company may benefit from aligning its strategies with industry standards and the initiatives of its parent company to enhance its environmental performance and accountability.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 9,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 87,086,632 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
US Bionics, Inc.'s Scope 3 emissions, which decreased by 3% last year and increased by approximately 173% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
US Bionics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.